# A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma

> **NCT00051181** · PHASE3 · COMPLETED · sponsor: **Alcon Research**

## Conditions studied

- Glaucoma, Angle-Closure
- Ocular Hypertension

## Interventions

- **DRUG:** Travoprost (0.004%)
- **DRUG:** Latanoprost (0.005%)

## Key facts

- **NCT ID:** NCT00051181
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** 2003-06
- **Final completion:** 2003-06
- **Target enrollment:** — (—)
- **Last updated:** 2008-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00051181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00051181, "A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00051181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*